Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PRECISION BIOSCIENCES INCDTIL · Entity 6284 | Chief Operating Officer | June 23, 2021 | June 25, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PRECISION BIOSCIENCES INC
Report date June 23, 2021 · Filed June 25, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 111,513 |
Ending reported balance
After 2021-06-23 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2021-06-23 · Exercise / conversion · Acquired 30,000 · Balance 141,513 Row 2 · 2021-06-23 · Sale · Disposed 30,000 · Balance 111,513 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.61 to $10.69. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.18 · Expires 2027-06-29 | Direct | 19,255 |
Reported balance
After 2021-06-23 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2021-06-23 · Exercise / conversion · Disposed 30,000 · Balance 19,255 F2: The option is fully vested and exercisable. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.61 to $10.69. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2: The option is fully vested and exercisable.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 23, 2021 Filed Jun 25, 2021 11:59 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $1.18 | $0.00 |
DisclosureSEC source: 0001209191-21-043206 · doc4.xml · derivative · entry 3 THOMSON DAVID S. · CIK 0001770315 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,255 Underlying: Common Stock · 30,000 shares Expires 2027-06-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| June 23, 2021 Filed Jun 25, 2021 11:59 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | SaleCommon Stock | 30,000 | $10.65 | $319,500.00 |
DisclosureSEC source: 0001209191-21-043206 · doc4.xml · nonDerivative · entry 2 THOMSON DAVID S. · CIK 0001770315 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,513 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.61 to $10.69. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 23, 2021 Filed Jun 25, 2021 11:59 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionCommon Stock | 30,000 | $1.18 | $35,400.00 |
DisclosureSEC source: 0001209191-21-043206 · doc4.xml · nonDerivative · entry 1 THOMSON DAVID S. · CIK 0001770315 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,513 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 21, 2021 Filed Jun 23, 2021 23:24 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $1.18 | $0.00 |
DisclosureSEC source: 0001209191-21-042844 · doc4.xml · derivative · entry 3 THOMSON DAVID S. · CIK 0001770315 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,255 Underlying: Common Stock · 15,000 shares Expires 2027-06-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| June 21, 2021 Filed Jun 23, 2021 23:24 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | SaleCommon Stock | 15,000 | $10.77 | $161,550.00 |
DisclosureSEC source: 0001209191-21-042844 · doc4.xml · nonDerivative · entry 2 THOMSON DAVID S. · CIK 0001770315 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,513 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.75 to $10.81. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 21, 2021 Filed Jun 23, 2021 23:24 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionCommon Stock | 15,000 | $1.18 | $17,700.00 |
DisclosureSEC source: 0001209191-21-042844 · doc4.xml · nonDerivative · entry 1 THOMSON DAVID S. · CIK 0001770315 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,513 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 18, 2021 Filed Jun 21, 2021 20:23 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $1.18 | $0.00 |
DisclosureSEC source: 0001209191-21-041996 · doc4.xml · derivative · entry 6 THOMSON DAVID S. · CIK 0001770315 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,255 Underlying: Common Stock · 10,000 shares Expires 2027-06-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| June 18, 2021 Filed Jun 21, 2021 20:23 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | SaleCommon Stock | 10,000 | $11.00 | $110,000.00 |
DisclosureSEC source: 0001209191-21-041996 · doc4.xml · nonDerivative · entry 4 THOMSON DAVID S. · CIK 0001770315 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,513 Read SEC document |
| June 18, 2021 Filed Jun 21, 2021 20:23 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionCommon Stock | 10,000 | $1.18 | $11,800.00 |
DisclosureSEC source: 0001209191-21-041996 · doc4.xml · nonDerivative · entry 3 THOMSON DAVID S. · CIK 0001770315 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,513 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 20:23 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $1.18 | $0.00 |
DisclosureSEC source: 0001209191-21-041996 · doc4.xml · derivative · entry 5 THOMSON DAVID S. · CIK 0001770315 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,255 Underlying: Common Stock · 10,000 shares Expires 2027-06-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 20:23 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | SaleCommon Stock | 10,000 | $10.44 | $104,400.00 |
DisclosureSEC source: 0001209191-21-041996 · doc4.xml · nonDerivative · entry 2 THOMSON DAVID S. · CIK 0001770315 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,513 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.39 to $10.48. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 20:23 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionCommon Stock | 10,000 | $1.18 | $11,800.00 |
DisclosureSEC source: 0001209191-21-041996 · doc4.xml · nonDerivative · entry 1 THOMSON DAVID S. · CIK 0001770315 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,513 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 20:06 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 2,858 | $0.00 Strike: $1.18 | $0.00 |
DisclosureSEC source: 0001209191-21-040888 · doc4.xml · derivative · entry 3 THOMSON DAVID S. · CIK 0001770315 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,255 Underlying: Common Stock · 2,858 shares Expires 2027-06-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 20:06 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | SaleCommon Stock | 2,858 | $11.20 | $32,009.60 |
DisclosureSEC source: 0001209191-21-040888 · doc4.xml · nonDerivative · entry 2 THOMSON DAVID S. · CIK 0001770315 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,513 Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 20:06 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionCommon Stock | 2,858 | $1.18 | $3,372.44 |
DisclosureSEC source: 0001209191-21-040888 · doc4.xml · nonDerivative · entry 1 THOMSON DAVID S. · CIK 0001770315 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,371 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 11, 2021 Filed Jun 15, 2021 20:19 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $1.18 | $0.00 |
DisclosureSEC source: 0001209191-21-040570 · doc4.xml · derivative · entry 3 THOMSON DAVID S. · CIK 0001770315 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,113 Underlying: Common Stock · 30,000 shares Expires 2027-06-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| June 11, 2021 Filed Jun 15, 2021 20:19 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | SaleCommon Stock | 30,000 | $11.52 | $345,600.00 |
DisclosureSEC source: 0001209191-21-040570 · doc4.xml · nonDerivative · entry 2 THOMSON DAVID S. · CIK 0001770315 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,513 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.50 to $11.68. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 11, 2021 Filed Jun 15, 2021 20:19 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionCommon Stock | 30,000 | $1.18 | $35,400.00 |
DisclosureSEC source: 0001209191-21-040570 · doc4.xml · nonDerivative · entry 1 THOMSON DAVID S. · CIK 0001770315 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,513 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 2,270 additional shares acquired under the Company's 2019 Employee Stock Purchase Plan since the Reporting Person's ownership report filed on January 25, 2021. Read SEC document |
| January 21, 2021 Filed Jan 25, 2021 13:00 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | SaleCommon Stock | 10,000 | $16.49 | $164,900.00 |
DisclosureSEC source: 0001209191-21-005016 · doc4.xml · nonDerivative · entry 1 THOMSON DAVID S. · CIK 0001770315 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,243 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · balance_after: Includes 2,130 additional shares acquired under the Company's 2019 Employee Stock Purchase Plan since the Reporting Person's ownership report filed on June 12, 2019. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 21:00 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | GrantEmployee Stock Option (Right to Buy) · Derivative | 154,891 | $0.00 Strike: $8.21 | $0.00 |
DisclosureSEC source: 0001209191-20-035568 · doc4.xml · derivative · entry 1 THOMSON DAVID S. · CIK 0001770315 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,891 Underlying: Common Stock · 154,891 shares Expires 2030-06-07 F1 · derivative.exercise_date: The option vests as to 25% of the underlying shares on April 1, 2021 and vests in equal installments at the end of each successive three-month period over the 36 months following such date. Read SEC document |
| September 23, 2019 Filed Sep 25, 2019 20:25 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | GrantEmployee Stock Option (Right to Buy) · Derivative | 30,922 | $0.00 Strike: $9.46 | $0.00 |
DisclosureSEC source: 0001209191-19-050702 · doc4.xml · derivative · entry 1 THOMSON DAVID S. · CIK 0001770315 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,922 Underlying: Common Stock · 30,922 shares Expires 2029-09-22 F1 · derivative.exercise_date: The option vests as to 25% of the underlying shares on April 1, 2020 and vests in equal installments at the end of each successive three-month period over the 36 months following such date. Read SEC document |
| June 10, 2019 Filed Jun 12, 2019 14:26 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 117,113 | $0.00 Strike: $1.18 | $0.00 |
DisclosureSEC source: 0001209191-19-036286 · doc4.xml · derivative · entry 2 THOMSON DAVID S. · CIK 0001770315 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,113 Underlying: Common Stock · 117,113 shares Expires 2027-06-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vests as to 25% of the underlying shares on May 31, 2018 and vests in equal installments at the end of each successive three-month period over the following 36 months. Read SEC document |
| June 10, 2019 Filed Jun 12, 2019 14:26 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionCommon Stock | 117,113 | $1.18 | $138,193.34 |
DisclosureSEC source: 0001209191-19-036286 · doc4.xml · nonDerivative · entry 1 THOMSON DAVID S. · CIK 0001770315 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,113 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.